Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 9, 2018 - The FDA approved Icon Bioscience’s Dexycu (dexamethasone intraocular suspension), for the treatment of postoperative inflammation.
Download PDF
Return to publications
